For decades, Alzheimer's research has focused on examining amyloid plaques in the brain and prescribing antibody therapeutics that remove the plaques to slow cognitive decline in patients.

Researchers at the Allen Institute for Brain Science, UW Medicine, and Kaiser Permanente Washington Health Research Institute ...

Higher levels of HDL-C -- known as the 'good cholesterol' -- have been shown to correlate with heightened risk for Alzheimer's disease. A new study might explain why.

How do we distinguish threat from safety? It's an important question not just in our daily lives, but for human disorders ...